StockGlow

Jaguar Health, Inc. (JAGX)

Makes plant-based medicines treating diarrhea in humans and animals.

$0.99-0.01%Healthcare
Compare JAGX with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-98.6%

The outlook

JAGX is trading near its 52-week low at $0.99, well below both its 50- and 200-day moving averages, reflecting a prolonged downtrend. Analyst coverage appears thin or absent from the data provided. The overall sentiment leans decidedly bearish based on current price action and technical positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$4.9M
52-wk high
$92.75
52-wk low
$0.91
50-day avg
$2.61
200-day avg
$25.54
Trailing P/E
—

Similar stocks

OCGNOcugen, Inc.$1.22-3.57%BNGOBionano Genomics, Inc.$1.10+1.39%TNXPTonix Pharmaceuticals Holding Corp.$10.26-1.06%MBAICheck-Cap Ltd.$1.03-3.74%CTRMCastor Maritime Inc.$1.87+0.76%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy